<p>Hozefa Bandukwala is vice president and science partner at Flagship Pioneering and currently serves as interim chief scientific officer at Apriori Bio. Prior to joining Flagship, he held several senior roles in the industry including Vice President of Platform Biology at Sigilon Therapeutics, Senior Director and Head of Discovery Biology at Rheos Medicines, and Head of the Immunometabolism Laboratory at Pfizer, where he pioneered novel target discovery in the field of immunometabolism.<br><br>Hozefa received his Ph.D. in Immunology from University of Chicago and completed his postdoctoral fellowship at Harvard University, where he conducted research on epigenetic and metabolic regulation of T cell functions. He received his B.S. in Biotechnology from the Indian Institute of Technology in Bombay.</p>

large_Bandukwala_Final_2 (1).jpg

Hozefa Bandukwala, PhD

CSO, Apriori Bio

Vice President and Science Partner, Flagship Pioneering